Home » Trinity Biotech Wraps Up RDI Deal
Trinity Biotech Wraps Up RDI Deal
Diagnostic products maker Trinity Biotech has acquired the business of Research Diagnostics (RDI) for $4.2 million in cash. New Jersey-based RDI provides a comprehensive range of immunodiagnostic products to research facilities, pharmaceutical companies, laboratories, diagnostic manufacturers and universities worldwide.
RTE News (http://www.rte.ie/business/2005/0321/trinity.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May